Moderna says Covid-19 vaccine won't to be ready before US elections: Report

Moderna Inc will not be ready to apply for emergency authorization for its potential Covid-19 vaccine before the U.S. presidential election in November, the Financial Times reported on Wednesday, citing the company's chief executive officer.

Stephane Bancel told FT that he did not expect to have full approval to distribute the drug to all sections of the U.S. population until next spring. 

Moderna did not immediately respond to Reuters request for comment.

Moderna will not be ready to seek emergency use authorization from the Food and Drug Administration before Nov. 25 at the earliest, the report said, citing Bancel.

The company's experimental vaccine is